Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

L Robert Nostrand Van


  • Director at Yield10 Bioscience Inc. (YTEN), 2019-10-02
  • Director at Intra-Cellular Therapies Inc. (ITCI), 2019-10-02
  • Director at Sellas Life Sciences Group Inc. (SLS), 2019-03-18
  • Director at Achillion Pharmaceuticals Inc (ACHN), 2019-01-25
  • Director at Enumeral Biomedical Holdings Inc. (ENUM), 2017-01-05
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ITCI $14.48 345 Director 3,656 2017-12-29 Filing
MBLX $1.07 20,000 Director 20,000 2012-11-30 Filing